Globe Life (NYSE:GL – Get Free Report) updated its FY 2026 earnings guidance on Wednesday morning. The company provided EPS guidance of 15.550-15.950 for the period, compared to the consensus earnings per share estimate of 15.650. The company issued revenue guidance of -.
Wall Street Analyst Weigh In
Several research firms have weighed in on GL. Piper Sandler increased their price target on shares of Globe Life from $175.00 to $200.00 and gave the company an “overweight” rating in a report on Wednesday, July 15th. Jefferies Financial Group boosted their price objective on Globe Life from $147.00 to $166.00 and gave the stock a “hold” rating in a report on Friday, July 10th. Keefe, Bruyette & Woods increased their target price on Globe Life from $180.00 to $192.00 and gave the stock an “outperform” rating in a research note on Monday, July 13th. Wells Fargo & Company lifted their price target on Globe Life from $172.00 to $193.00 and gave the stock an “overweight” rating in a report on Thursday, July 9th. Finally, Morgan Stanley boosted their price target on Globe Life from $181.00 to $208.00 and gave the company an “overweight” rating in a research note on Monday, July 6th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, Globe Life presently has an average rating of “Moderate Buy” and a consensus price target of $187.60.
Read Our Latest Stock Analysis on Globe Life
Globe Life Stock Performance
Globe Life (NYSE:GL – Get Free Report) last released its quarterly earnings results on Wednesday, July 22nd. The company reported $3.61 EPS for the quarter, missing analysts’ consensus estimates of $3.67 by ($0.06). Globe Life had a net margin of 19.38% and a return on equity of 20.94%. The company had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter last year, the firm posted $3.05 EPS. The company’s quarterly revenue was up 8.0% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. On average, equities analysts forecast that Globe Life will post 15.64 earnings per share for the current fiscal year.
Globe Life Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Monday, July 6th will be given a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Monday, July 6th. Globe Life’s dividend payout ratio is currently 9.13%.
Insider Activity at Globe Life
In related news, CEO James Matthew Darden sold 4,663 shares of the business’s stock in a transaction on Tuesday, April 28th. The stock was sold at an average price of $153.88, for a total transaction of $717,542.44. Following the sale, the chief executive officer directly owned 58,451 shares in the company, valued at approximately $8,994,439.88. The trade was a 7.39% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Frank M. Svoboda sold 20,000 shares of the business’s stock in a transaction dated Friday, May 22nd. The stock was sold at an average price of $156.68, for a total value of $3,133,600.00. Following the transaction, the chief executive officer owned 54,020 shares of the company’s stock, valued at approximately $8,463,853.60. The trade was a 27.02% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 124,187 shares of company stock worth $19,529,414 in the last three months. Corporate insiders own 2.11% of the company’s stock.
Globe Life News Summary
Here are the key news stories impacting Globe Life this week:
- Positive Sentiment: Globe Life reported second-quarter results showing improved profitability, with net operating income of $3.61 per share versus $3.27 a year ago, while revenue rose 8% year over year to $1.60 billion. Globe Life Inc. Reports Second Quarter 2026 Results
- Positive Sentiment: Reuters and other reports highlighted strong underwriting income, suggesting Globe Life’s core insurance operations are performing well and helping offset the earnings miss. Insurer Globe Life’s second-quarter profit rises on strong underwriting income
- Positive Sentiment: TD Cowen raised its price target on Globe Life to $225 from $215 and kept a Buy rating, while JPMorgan lifted its target to $201 and maintained an Overweight rating, signaling continued analyst confidence. Analyst price target update
- Neutral Sentiment: Globe Life’s EPS of $3.61 missed the consensus estimate of $3.67 by $0.06, which partially offsets the positive revenue and underwriting trends. Globe Life (GL) Q2 Earnings Lag Estimates
- Neutral Sentiment: The company guided FY 2026 EPS to $15.55-$15.95, which is broadly in line with Street expectations and suggests management remains confident but not dramatically more optimistic. Press Release
Institutional Inflows and Outflows
Large investors have recently bought and sold shares of the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of Globe Life by 6.9% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,391 shares of the company’s stock worth $1,237,000 after purchasing an additional 607 shares during the last quarter. NewEdge Advisors LLC lifted its stake in shares of Globe Life by 368.1% in the first quarter. NewEdge Advisors LLC now owns 6,806 shares of the company’s stock worth $897,000 after buying an additional 5,352 shares in the last quarter. Goldman Sachs Group Inc. increased its position in shares of Globe Life by 11.5% during the first quarter. Goldman Sachs Group Inc. now owns 563,021 shares of the company’s stock valued at $74,161,000 after acquiring an additional 58,163 shares in the last quarter. Empowered Funds LLC purchased a new position in Globe Life in the 1st quarter worth approximately $428,000. Finally, Focus Partners Wealth lifted its position in Globe Life by 8.3% in the 1st quarter. Focus Partners Wealth now owns 8,559 shares of the company’s stock valued at $1,127,000 after acquiring an additional 656 shares in the last quarter. 81.61% of the stock is owned by hedge funds and other institutional investors.
Globe Life Company Profile
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
Featured Articles
- Five stocks we like better than Globe Life
- Philip Morris Trimmed Guidance, But Its Growth Story Looks Unshaken
- Cementing the Sky: Why NVIDIA’s Bet on Nebius Matters
- Forging Profits: The Executive Order Sparking Aluminum
- Thematic Memory ETFs Give Investors a New Way to Play AI’s Hidden Bottleneck
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.
